154 related articles for article (PubMed ID: 16191686)
1. Classification of Marek's disease viruses according to pathotype: philosophy and methodology.
Witter RL; Calnek BW; Buscaglia C; Gimeno IM; Schat KA
Avian Pathol; 2005 Apr; 34(2):75-90. PubMed ID: 16191686
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Marek's disease field isolates by the "best fit" pathotyping assay.
Dudnikova E; Norkina S; Vlasov A; Slobodchuk A; Lee LF; Witter RL
Avian Pathol; 2007 Apr; 36(2):135-43. PubMed ID: 17479374
[TBL] [Abstract][Full Text] [Related]
3. ["Best fit" pathotyping of field Marek's (big liver) disease virus strains isolated in the Russian Federation in 2001-2005].
Dudnikova EK; Hopkina SN; Aliper TI; Vlasov AN; Dzhulardov GV; Lee L; Witter R
Vopr Virusol; 2009; 54(1):36-41. PubMed ID: 19253730
[TBL] [Abstract][Full Text] [Related]
4. Increased virulence of Marek's disease virus field isolates.
Witter RL
Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the attenuation of serotype 1 Marek's disease virus by serial cell culture passage and evaluation of attenuated strains for protection and replication.
Dudnikova E; Vlasov A; Norkina S; Kireev D; Witter RL
Avian Dis; 2009 Mar; 53(1):63-72. PubMed ID: 19432005
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Marek's disease virus pathotype and replication.
Dunn JR; Auten K; Heidari M; Buscaglia C
Avian Dis; 2014 Jun; 58(2):287-92. PubMed ID: 25055634
[TBL] [Abstract][Full Text] [Related]
9. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains.
Yunis R; Jarosinski KW; Schat KA
Virology; 2004 Oct; 328(1):142-50. PubMed ID: 15380365
[TBL] [Abstract][Full Text] [Related]
10. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and Identification of Marek's Disease Virus BAC Clones as Standardized Reagents for Research.
Dunn JR; Reddy SM; Niikura M; Nair V; Fulton JE; Cheng HH
Avian Dis; 2017 Mar; 61(1):107-114. PubMed ID: 28301231
[TBL] [Abstract][Full Text] [Related]
12. Pathotyping of Australian isolates of Marek's disease virus and association of pathogenicity with meq gene polymorphism.
Renz KG; Cooke J; Clarke N; Cheetham BF; Hussain Z; Fakhrul Islam AF; Tannock GA; Walkden-Brown SW
Avian Pathol; 2012; 41(2):161-76. PubMed ID: 22515535
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterisation of two Australian isolates of Marek's disease virus including pathology, viral load and neuropathotyping based on clinical signs.
Wajid SJ; Walkden-Brown SW; Vanselow BA; Islam AF; Renz KG
Aust Vet J; 2015 Jul; 93(7):240-7. PubMed ID: 26113349
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of factors influencing the development of late Marek's disease virus-induced immunosuppression: virus pathotype and host sex.
Faiz NM; Cortes AL; Guy JS; Fletcher OJ; Cimino T; Gimeno IM
Avian Pathol; 2017 Aug; 46(4):376-385. PubMed ID: 28151004
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
16. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
17. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
Hildebrandt E; Dunn JR; Cheng HH
Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency.
Witter RL
Avian Dis; 1983; 27(1):113-32. PubMed ID: 6303287
[TBL] [Abstract][Full Text] [Related]
19. Late Marek's disease in adult chickens inoculated with virulent Marek's disease virus.
Ikezawa M; Goryo M; Sasaki J; Haridy M; Okada K
J Vet Med Sci; 2010 Dec; 72(12):1539-45. PubMed ID: 20651465
[TBL] [Abstract][Full Text] [Related]
20. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
Karpathy RC; Firth GA; Tannock GA
Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
